Home › Trial NCT01621425
Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity
- Trial IDNCT01621425
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorRadboud University Medical Center
- Enrollment25
- Start date2012-06
- ConditionsBreast Cancer · Metastatic Castration-resistant Prostate Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.